Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Authors: Koshkin, Vadim S., Henderson, Nicholas, James, Marihella, Natesan, Divya, Freeman, Dory, Nizam, Amanda, Su, Christopher T., Khaki, Ali Raza, Osterman, Chelsea K., Glover, Michael J., Chiang, Ryan, Makrakis, Dimitrios, Talukder, Rafee, Lemke, Emily, Olsen, T. Anders, Jain, Jayanshu, Jang, Albert, Ali, Alicia, Jindal, Tanya, Chou, Jonathan, Friedlander, Terence W., Hoimes, Christopher, Basu, Arnab, Zakharia, Yousef, Barata, Pedro C., Bilen, Mehmet A., Emamekhoo, Hamid, Davis, Nancy B., Shah, Sumit A., Milowsky, Matthew I., Gupta, Shilpa, Campbell, Matthew T., Grivas, Petros, Sonpavde, Guru P., Kilari, Deepak, Alva, Ajjai S.

Source: Cancer. 128(6):1194-1205

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100142031419.0x000001&indx=1&recIds=ETOCvdc_100142031419.0x000001

DNA damage repair alterations as predictive biomarker for platinum-based chemotherapy in metastatic urothelial cancer.

Authors: Sternschuss, Michal, Paynter, Alexander, Xu, Wenxin, Nichols, Chelsea, Hoppe, Jennifer, Davis, Nancy B, Jiang, Di Maria, Shah, Neil J.

Source: Journal of Clinical Oncology; 2/20/2025 Supplement 5, Vol. 43, p853-853, 242p

Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review‐based cohort study

Authors: Dymanus, Kyle A., Butaney, Mohit, Magee, Diana E., Hird, Amanda E., Luckenbaugh, Amy N., Ma, Merry W., Hall, Mary E., Huelster, Heather L., Laviana, Aaron A., Davis, Nancy B., Terris, Martha K., Klaassen, Zachary, Wallis, Christopher J. D.

Source: Cancer. 127(17):3156-3162

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125702201.0x000001&indx=1&recIds=ETOCvdc_100125702201.0x000001

Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study

Authors: Ornstein, Moshe C ^*, Pal, Sumanta K, Wood, Laura S, Tomer, Jackie M, Hobbs, Brian P, Jia, Xuefei S, Allman, Kimberly D, Martin, Allison, Olencki, Thomas, Davis, Nancy B, Gilligan, Timothy D, Mortazavi, Amir, Rathmell, W Kimryn, Garcia, Jorge A, Rini, Brian I

Source: In The Lancet Oncology October 2019 20(10):1386-1394

Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data

Authors: Jindal, Tanya ^a, Jiang, Cindy ^b, Alhalabi, Omar ^b, Nizam, Amanda ^c, Nguyen, Charles ^d, Talukder, Rafee ^e, Bakaloudi, Dimitra ^e, Davidsohn, Matthew ^f, Freeman, Dory ^f, Glover, Michael ^g, Khaki, Ali Raza ^g, Evans, Sean ^h, Lemke, Emily ⁱ, Bose, Rohit ^a, Sim, Woogwang ^a, Pywell, Cameron ^j, Basu, Arnab ^j, Kilari, Deepak ⁱ, Barata, Pedro C. ^k, Bilen, Mehmet A. ^h, Zakharia, Yousef ^l, Milowsky, Matthew I. ^m, Shah, Sumit A. ^g, Bellmunt, Joaquim ^f, Grivas, Petros ⁿ, Emamekhoo, Hamid ^o, Davis, Nancy B. ^p, Gupta, Shilpa ^c, Hoimes, Christopher ^q, Campbell, Matthew T. ^b, Alva, Ajjai ^d, Koshkin, Vadim S. ^{a, ⁎}

Source: In European Urology Oncology April 2025 8(2):258-262

Editorial: Bladder preservation options for bladder cancer.

Authors: Davis, Nancy B., Kilari, Deepak, Kessler, Elizabeth R., Smelser, Woodson W.

Source: Frontiers in Oncology; 2024, p1-3, 3p

Subject Terms: NON-muscle invasive bladder cancer, TRANSURETHRAL resection of bladder, SMALL cell lung cancer, CANCER invasiveness, BLADDER cancer, URINARY diversion

Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.

Authors: Grivas, Petros, Pouessel, Damien, Park, Chandler H., Barthelemy, Philippe, Bupathi, Manojkumar, Petrylak, Daniel P., Agarwal, Neeraj, Gupta, Sumati, Fléchon, Aude, Ramamurthy, Chethan, Davis, Nancy B., Recio-Boiles, Alejandro, Sternberg, Cora N., Bhatia, Astha, Pichardo, Cabilia, Sierecki, Mitch, Tonelli, Julia, Zhou, Huafeng, Tagawa, Scott T., Loriot, Yohann

Source: Journal of Clinical Oncology; 4/20/2024, Vol. 42 Issue 12, p1415-1425, 14p

Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline

Authors: Nekhlyudov, Larissa, Lacchetti, Christina, Davis, Nancy B.

Source: Journal of clinical oncology. 35(14):1606-1621

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN611195691&indx=1&recIds=ETOCRN611195691

Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin.

Authors: Fahey, Catherine C., Nebhan, Caroline A., York, Sally, Davis, Nancy B., Hurley, Paula J., Gordetsky, Jennifer B., Schaffer, Kerry R.

Source: International Journal of Molecular Sciences; Nov2023, Vol. 24 Issue 22, p16109, 8p

Subject Terms: SQUAMOUS cell carcinoma, PENILE cancer, ANTIBODY-drug conjugates, PROGRESSION-free survival, METASTASIS, RARE diseases

A Comparative Study of Two Pre-School Assessments and Their Relationships to School Achievement.

Authors: Davis, Nancy B.

Peer Reviewed: N

Page Count: 157

Descriptors: Academic Achievement, Cognitive Development, Comparative Testing, Developmental Tasks, Educational Assessment, Grade 1, High Achievement, Kindergarten Children, Low Achievement, Piagetian Theory, Predictive Measurement, Preschool Education, School Readiness Tests, Screening Tests, Test Selection

Geographic Terms: Idaho

An Individualized Reading Program.

Authors: Davis, Nancy B., Self Instructional Reading Service, Bloomington, IN.

Peer Reviewed: N

Page Count: 11

Descriptors: Autoinstructional Aids, College Programs, Individualized Instruction, Individualized Reading, Noncredit Courses, Reading Centers, Skill Centers, Study Skills, Tape Recordings

Journal Code: RIEAPR1970

TROPHY-U-01 Cohort 3: Sacituzumab govitecan (SG) in combination with pembrolizumab (Pembro) in patients (pts) with metastatic urothelial cancer (mUC) who progressed after platinum (PLT)-based regimens.

Authors: Grivas, Petros, Pouessel, Damien, Park, Chandler H., Barthélémy, Philippe, Bupathi, Manojkumar, Petrylak, Daniel P., Agarwal, Neeraj, Flechon, Aude, Ramamurthy, Chethan, Davis, Nancy B., Recio-Boiles, Alejandro, Tagawa, Scott T., Sternberg, Cora N., Bhatia, Astha, Pichardo, Cabilia, Goswami, Trishna, Loriot, Yohann

Source: Journal of clinical oncology. 40(6 suppl):434-434

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152993489.0x000001&indx=1&recIds=ETOCvdc_100152993489.0x000001

Association between on-treatment eosinophil dynamics and outcomes in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab.

Authors: Chen, Yu-Wei, Tucker, Matthew D, Yasin, Hesham, Ancell, Kristin Kathleen, Davis, Nancy B., Haake, Scott Mattox, Kaiser, Elizabeth, McAlister, Renee, Rathmell, Wendy Kimryn, Schaffer, Kerry, Wallace, Deborah, Beckermann, Katy, Rini, Brian I.

Source: Journal of clinical oncology. 40(6 suppl):364-364

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152990590.0x000001&indx=1&recIds=ETOCvdc_100152990590.0x000001

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984.

Authors: Kim, Joseph W., McKay, Rana R., Radke, Marc R., Zhao, Shilin, Taplin, Mary-Ellen, Davis, Nancy B., Monk, Paul, Appleman, Leonard J., Lara Jr, Primo N., Vaishampayan, Ulka N., Zhang, Jingsong, Paul, Asit K., Bubley, Glenn, Van Allen, Eliezer M., Unlu, Serhan, Huang, Ying, Loda, Massimo, Shapiro, Geoffrey I., Glazer, Peter M., LoRusso, Patricia M.

Source: Journal of Clinical Oncology; 2/1/2023, Vol. 41 Issue 4, p871-880, 10p

A University of Chicago Consortium Phase II Trial of SB-715992 in Advanced Renal Cell Cancer

Authors: Lee, Richard T., Beekman, Kathleen E., Hussain, Maha, Davis, Nancy B., Clark, Joseph I., Thomas, Sachdev P., Nichols, Katherine F., Stadler, Walter M.

Source: In Clinical Genitourinary Cancer 2008 6(1):21-24

Outcomes with novel combinations in non-clear cell renal cell carcinoma(nccRCC): ORACLE study.

Authors: Kilari, Deepak, Szabo, Aniko, Ghatalia, Pooja, Rose, Tracy L, Weise, Nicole, Tucker, Matthew D., Nelson, Ariel Ann, Dong, Huaying, Hester, Danubia, Acharya, Luna, Jain, Rohit K., Maughan, Benjamin L., Alva, Ajjai Shivaram, Tripathi, Abhishek, Basu, Arnab, Koshkin, Vadim S, Emamekhoo, Hamid, Davis, Nancy B., Desai, Arpita, McKay, Rana R.

Source: Journal of clinical oncology. 39(15 suppl):4580-4580

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173202797.0x000001&indx=1&recIds=ETOCvdc_100173202797.0x000001

A phase 2 study of cabozantinib in combination with atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer (HCRN GU18-343) ABATE study.

Authors: Kilari, Deepak, Szabo, Aniko, Bylow, Kathryn A., Alter, Robert S., Nelson, Ariel Ann, Lemke, Emily, Hall, William Adrian, Johnson, Scott, Langenstroer, Peter, Jacobsohn, Kenneth, Davis, Nancy B., Fung, Chunkit, Milowsky, Matthew I.

Source: Journal of clinical oncology. 39(15 suppl):TPS4591-TPS4591

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173202916.0x000001&indx=1&recIds=ETOCvdc_100173202916.0x000001

Association of baseline neutrophil-to-eosinophil ratio (NER) and neutrophil-to-lymphocyte ratio (NLR) with response to combination immunotherapy (IO) with ipilimumab plus nivolumab (ipi/nivo) in patients with metastatic renal cell carcinoma (mRCC).

Authors: Tucker, Matthew D., Brown, Landon Carter, Kao, Chester, Hirshman, Nathan, Kinsey, Emily Noelle, Chen, Yu-Wei, Ancell, Kristin Kathleen, Beckermann, Katy, Davis, Nancy B., McAlister, Renee, Schaffer, Kerry, Armstrong, Andrew J., Harrison, Michael Roger, George, Daniel J., Rathmell, Wendy Kimryn, Rini, Brian I., Zhang, Tian

Source: Journal of clinical oncology. 39(15 suppl):4563-4563

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173202582.0x000001&indx=1&recIds=ETOCvdc_100173202582.0x000001

CANTATA: Primary analysis of a global, randomized, placebo (Pbo)-controlled, double-blind trial of telaglenastat (CB-839) + cabozantinib versus Pbo + cabozantinib in advanced/metastatic renal cell carcinoma (mRCC) patients (pts) who progressed on immune checkpoint inhibitor (ICI) or anti-angiogenic therapies.

Authors: Tannir, Nizar M., Agarwal, Neeraj, Porta, Camillo, Lawrence, Nicola Jane, Motzer, Robert J., Lee, Richard J., Jain, Rohit K., Davis, Nancy B., Appleman, Leonard Joseph, Goodman, Oscar B., Stadler, Walter Michael, Gandhi, Sunil G., Geynisman, Daniel M., Iacovelli, Roberto, Mellado, Begona, Figlin, Robert A., Powles, Thomas, Akella, Lalith V, Orford, Keith W., Escudier, Bernard

Source: Journal of clinical oncology. 39(15 suppl):4501-4501

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173201695.0x000001&indx=1&recIds=ETOCvdc_100173201695.0x000001

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.

Authors: Chen, Yu-Wei, Tucker, Matthew D., Brown, Landon C., Yasin, Hesham A., Ancell, Kristin K., Armstrong, Andrew J., Beckermann, Kathryn E., Davis, Nancy B., Harrison, Michael R., Kaiser, Elizabeth G., McAlister, Renee K., Schaffer, Kerry R., Wallace, Deborah E., George, Daniel J., Rathmell, W. Kimryn, Rini, Brian I., Zhang, Tian

Source: Cancers; Aug2022, Vol. 14 Issue 15, p3830-3830, 14p

Subject Terms: EOSINOPHILS, RENAL cell carcinoma, IMMUNE checkpoint inhibitors, ACADEMIC medical centers, MULTIVARIATE analysis, MONOCLONAL antibodies, METASTASIS, RETROSPECTIVE studies, REGRESSION analysis, NEUTROPHILS, TREATMENT effectiveness, KIDNEY tumors, RESEARCH funding, PROGRESSION-free survival

Geographic Terms: UNITED States